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Abstract
Liprin-a4 was strongly induced following nickel (II) chloride exposure in a variety of cell types including BEAS-2B, A549,
BEP2D and BL41 cells. Liprin-a4, a member of the Liprin alpha family, has seven isoforms but only three of these variants
were detected in BEAS-2B cells (004, 201 and 202). The level of Liprin-a4 variants 201 and 004 were highly increased in BEAS-
2B cells in response to nickel. We showed that Liprin-a4 bound directly to the cytoplasmic region of RPTP-LAR (receptor
protein tyrosine phosphatase-leukocyte antigen-related receptor F). The cytoplasmic region of RPTP-LAR contains two
phosphatase domains but only the first domain shows activity. The second domain interacts with other proteins. The
phosphatase activity was increased both following nickel treatment and also in the presence of nickel ions in cell extracts.
Liprin-a4 knock-down lines with decreased expression of Liprin-a4 variants 004 and 201 exhibited greater nickel toxicity
compared to controls. The RPTP-LAR phosphatase activity was only slightly increased in a Liprin-a4 knock-down line. Liprin-
a4 appeared necessary for the nickel induced tyrosine phosphatase activity. The presence of Liprin-a4 and nickel increased
tyrosine phosphatase activity that reduced the global levels of tyrosine phosphorylation in the cell.
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Introduction
The leucocyte common antigen-related (RPTP-LAR) protein is
a member of the receptor protein tyrosine phosphatase (RPTP) F
family that are single pass type I transmembrane receptor class 2A
proteins [1,2]. RPTP-LAR contains an extracellular region with
three immunoglobulin-like and eight fibronectin type III domains.
The cytoplasmic region of the RPTP-LAR protein includes two
protein tyrosine phosphatase (PTP) domains. The first cytoplasmic
domain exhibits enzymatic activity while the second domain
determines specificity of substrate binding [3,4]. RPTP-LAR plays
a role in metabolic and cellular processes by its ability to respond
to stimuli and transduce signals resulting in the regulation of
biological processes.
Protein tyrosine phosphatase, receptor type, F polypeptide
(PTPRF), interacting protein alpha 1 (PPFIA1), also known as
Liprin-a1, was first identified as a binding protein of RPTP-LAR
[5]. Liprin-a1 was required for the trafficking of synaptic vesicles
and was involved in the development and maintenance of
excitatory synapses [6,7]. Liprin-a1 also interacted with ING4,
one of five protein members of the inhibitor of growth family [8].
The ING proteins have been described as binders of histone
acetylases (HAT), histone deacetylases (HDAC) and histone
H3K4me3. The ING proteins are tumor suppressors of cancer
invasion and metastasis [9,10].
Liprin-a1 belongs to a family of liprin alpha proteins of which
there are four members. Characteristic structure motifs shared by
the family members include the N-terminal helical coil-coiled
domain and three C-terminal sterile alpha motifs (SAM). The
SAM domain is crucial for the direct interaction of Liprin-a1t o
the second cytosolic PTP domain of the RPTP-LAR protein
[11,12]. It has been shown that phosphorylated Liprin-a1
regulates its binding to the RPTP-LAR transmembrane protein-
tyrosine phosphatase. Liprin-a1 contains a C-terminal 100 amino
acid sequence which is characterized as a GRIP protein binding
site [13,14]. The same sequence could be identified in Liprin-a2
and Liprin-a3 but not in Liprin-a4. A multidomain protein known
as trio has also been described as an interacting partner of RPTP-
LAR [15]. Liprin-a1 remains the best characterized member of
the liprin alpha family. Similar to other family members, Liprin-a4
contains an N-terminal helical coil-coiled domain and three C-
terminal SAM domains. Liprin-a4 belongs in this family by
sequence comparison. Little is known about the cellular function
of Liprin-a4. Interestingly, compared to the other three members,
Liprin-a4 has the shortest N-terminal helical coiled-coil segment
and it lacks the C-terminal 100-amino acid GRIP binding site
found in Liprin-a1/2/3. However, the physiological function of
Liprin-a4 as well as its upstream regulator and downstream targets
remains largely unknown.
RNA-Seq data in A549 cells showed a more than 200-fold
increase in the expression of Liprin-a4 mRNA compared to the
control following a 24 h nickel exposure [15], suggesting a
potential involvement of Liprin-a4 in cellular responses to nickel.
Affymetrix Gene Chip array was employed to analyze the mRNA
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August  4expression pattern in normal human bronchial epithelial cells
(BEAS-2B) following nickel (II) chloride. An increased expression
of Liprin-a4 was found. Liprin-a4 protein and mRNA levels were
increased by nickel in several different cell types. In addition,
nickel was able to increase the phosphatase activity of RPTP-LAR
both in whole cells as well as directly using cell extracts and an in
vitro activity assay. Interestingly, liprin-a4 knockdown cells failed to
increase RPTR-LAR activity in the presence of nickel, indicating
that liprin-a4 was required for nickel induced phosphatase activity.
Moreover, in the absence of liprin-a4, immortalized human
bronchial epithelial cells were more sensitive to nickel induced
cytotoxicity. Thus, our results indicated that liprin-a4 may
function as a regulator of RPTP-LAR activity and has a protective
role in nickel induced cytotoxicity.
Results
BEAS-2B, A549, and BEP2D cells show a dose dependent
increase in Liprin-a4 mRNA after 24 h exposure to NiCl2
Affymetrix Gene Chip was used to analyze mRNA expression
changes in BEAS-2B cells 24 hours following exposure to
0.5 mM NiCl2. 206 genes were up regulated after nickel
treatment but only 66 genes were down-regulated more than
two fold. Table S1 contains a list of all 272 genes that were either
up or down regulated more than 2-fold following nickel exposure.
We have concentrated our studies on genes that were exclusively
up regulated following nickel treatment. To confirm the results of
the Affymetrix chip, the expression of Liprin-a4, HMOX1, CA9
and NDRG1 were verified by quantitative PCR (Figure S1).
HMOX1 showed a 3.8 fold increase after nickel treatment while
Ca9 and NDRG1 increased more than 2-fold. None of the other
members of the liprin alpha family (Liprin-a1, Liprin-a2 and
Liprin-a3) exhibited a change in mRNA expression after nickel
exposure (Figure 1A). The Liprin-a4 mRNA increased in a
concentration dependent manner (Figure 1B). The Gene Chip
array in BEAS-2B cells showed that Liprin-a4w a s3 . 7f o l du p -
regulated after 24 h nickel exposure (Figure 1A) and Liprin-a4
mRNA was increased after nickel treatment in comparison to
control), in a concentration dependent manner (Figure 1B).
Liprin-a4 was highly induced in A549, BEP2D, HOS, BL41 cells
and in human lymphocytes after 24 h nickel exposure (Figure 1C).
Quantitative real time PCR showed that the expression was
increased in A549 and BEP2D in a concentration dependent
manner. The qPCR for Liprin-a4 was performed with primers
that recognized all Liprin-a4i s o f o r m s .
Two of seven Liprin-a4 isoforms were increased in both
mRNA and protein in BEAS-2B cells exposed to NiCl2
According to the Ensembl database there are seven different
Liprin-a4 protein isoforms (http://uswest.ensembl.org). We have
analyzed the mRNA level of all the isoforms in untreated and
nickel treated BEAS-2B cells. For this experiment we used a
variant specific backward primer for reverse transcription. The
expression of the isoforms was analyzed by PCR in the absence
and presence of nickel. The variants 201, 202 and 004 were found
to be expressed in BEAS-2B cells (Figure 1D). The Liprin-a4
isoforms 201 and 004 showed an induction in mRNA expression
after nickel treatment; conversely, the expression of isoform 202
mRNA was not altered by nickel treatment. In addition to the
mRNA level of Liprin-a4 we also examined the protein level of
Liprin-a4 in BEAS-2B and A549 cells in the absence and presence
of nickel treatment. According to Ensemble database the various
Liprin-a4 isoforms resulted in different protein lengths as follows:
isoform 004 contained 136 amino acids with a molecular weight of
16 kDa, isoform 201 had 692 aminoacids with a molecular weight
of 78 kDa and isoform 202 contained 1186 aminoacids with a
molecular weight of 134 kDa. Further analyses were performed in
BEAS-2B and A549 lung cell lines but only the data from BEAS-
2B cells are shown. Two out of the three isoforms were found in
BEAS-2B cells based on staining with a Liprin-a4 Antibody
(abcam). The Liprin-a4 isoform 004 had a molecular weight of
16 kDa (Figure 1E). In addition to this isoform a 32 kDa protein
was also found which likely is the dimerized form of variant 004.
As with the RNA, the protein level of cytosolic/membrane
fraction of Liprin-a4 isoform 004 (16 kDa) and 201 (78 kDa) were
increased 24 h after nickel exposure, as well as an increase in the
possible 004 dimer of 32 kDa (Figure 1E). These two isoforms
were also detected in the nuclear fraction but their expression
levels in this fraction were unchanged by nickel treatment (data
not shown). The protein of variant 202 was not detected despite
the presence of mRNA.
Liprin-a4 interacted directly with RPTP-LAR
Another member of the liprin alpha family, Liprin-a1, has
been characterized as an interacting partner of RPTP-LAR.
Since the mRNA level of Liprin-a1/2/3 did not change by
nickel, the binding of Liprin-a4 to the cytoplasmic region of the
RPTP-LAR was studied to determine if Liprin-a4 might have an
effect similar to what would be expected for Liprin-a1.
Immunoprecipitation (IP) using the RPTP-LAR antibody was
performed to examine the direct interaction of RPTP-LAR with
the Liprin-a4. The RPTP-LAR IP showed an accumulation of
Liprin-a4 in control and after 24 h nickel exposure (Figure 2). We
demonstrated an slightly increased binding of Liprin-a4t o
RPTP-LAR in the presence of nickel. To study this binding,
cell lysate were incubated, with and without nickel, to protein A/
G agarose and RPTP-LAR antibody at 4uC overnight (Figure 2).
Liprin-a4 was induced by nickel and there was a direct
interaction between Liprin-a4 and RPTP-LAR.
Nickel increased the RPTP-LAR phosphatase activity and
reduced cellular tyrosine phosphorylation level
The effect of nickel on the activity of the RPTP-LAR
phosphatase using a mono tyrosine phosphorylated RPTP-LAR
substrate was examined by measuring the concentration of free
phosphates which were generated by the dephosporylation of
substrate. The phosphatase activity was measured in IP-RPTP-
LAR samples in the absence and presence of nickel. The reaction
in the absence of substrate was utilized as background and these
values were subtracted from each sample. The RPTP-LAR
phosphatase showed a higher activity in nickel treated cells
compared to both the control without enzyme and in the
untreated BEAS-2B and A549 cells (Figure 3A). We used the
monophosphorylated substrate (PTP Substrate 1-pTyr) from the
Insulin Receptor which was recognized by RPTP-LAR. In A549
cells the activity increased from 0.3 in control to 1.35 pmole/ug/
min after a 24 hrs 1 mM nickel treatment (non-toxic dose of Ni,
Figure 3A). There was a similar increase in BEAS-2B cells, from
1.15 to 4.33 pmole/ug/min after 0.5 mM nickel exposure (non-
toxic dose of nickel). In order to compare equally toxic nickel
doses we exposed the two cell lines to different nickel
concentrations, since BEAS-2B cells were twice as sensitive to
nickel compared to A549 cells. Additionally the activity of the
membrane bound RPTP-LAR tyrosine phosphatase was ana-
lyzed in the presence and absence of nickel in BEAS-2B and
A549 cells using a tyrosine phosphatase assay (Figure 3B). The
tyrosine phosphatase was more active in the presence of nickel.
The presence of 20 uM nickel in the reaction led to an increased
Nickel Induced RPTP-LAR Activity
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found an increase from 0.7 to 1.95 pmole/ug/min in BEAS-2B
cells (Figure 3B). An increased phosphatase activity was also
observed in the lung cell line BEP2D and in a bone cancer cell
line HOS 24 h following nickel exposure (Figure S2). The
tyrosine phosphorylation level of proteins after nickel exposure
was examined using western blot. Decreased tyrosine phosphor-
ylation levels in two cytoplasmic proteins were found after nickel
treatment by western blot (Figure 3C). The results in figure 3
represented multiple repeated experiments.
Figure 1. Expression of endogenous Liprin-a4 is up regulated after nickel treatment. (A) Gene Chip data showed expression for members
of the liprin alpha family. Expression of Liprin-a4 was up regulated after Ni treatment but other members of the liprin family Liprin-a1/2 and Liprin-a4
were unchanged after nickel. (B) Increasing expression of Liprin-a4 in BEAS-2B cells after 24 h nickel treatment. Liprin-a4 increases in a concentration
dependent manner in BEAS-2B cells. (C) Increasing expression of Liprin-a4 in different cell lines. The changes in expression were concentration
dependent in A549 and BEP2D cells. (D) The isoforms 201, 202 and 004 were present in BEAS-2B cell. Liprin-a4 variant 004 and 201 was increased
after nickel exposure. The isoform 202 was present in BEAS-2B cells but unchanged by nickel. (E) Western analysis shows induced Liprin-a4 protein
levels for isoforms 004 (16 and 32 kDa) and 201 (78 kDa) after nickel exposure.
doi:10.1371/journal.pone.0022764.g001
Figure 2. RPTP-LAR interacts with Liprin-a4. IP experiment was performed with RPTP-LAR antibody. Input shows an increasing level in Liprin-a4
after nickel treatment compared to the untreated control. Liprin-a4 binds to RPTP-LAR in absence and presence of nickel. The presence of nickel did
not affect the binding efficiency between RPTP-LAR and Liprin-a4. After nickel exposure more Liprin-a4 binds to RPTP-LAR than in control. In western
analysis we demonstrated an immunoprecipitation of Liprin-a4 and we showed an enrichment of Liprin-a4 that binds to the cytoplasmic region of
RPTP-LAR receptor after nickel treatment.
doi:10.1371/journal.pone.0022764.g002
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nickel and it attenuates the nickel induced increased
phosphatase
Two stable Liprin-a4 RNAi BEAS-2B cell lines were estab-
lished. The transcription of Liprin-a4 in both cell lines was
analyzed using quantitative PCR. In line 847 Liprin-a4 was
expressed at 80% of the RNA level of the control, while in cell line
323 the expression of Liprin-a4 was reduced to 50% (Figure 4A).
We showed that in the knock-down cell line 323, as compared to
the control, the variant 201 was reduced in expression, the variant
Liprin-a4 004 was not detectable by qPCR while the isoform 202
remained unchanged (Figure 4B). The protein level of Liprin-a4
was examined in the knock-down lines 323 and 847 (Figure 4C).
Western blot analysis reveals that the isoform 004 was reduced in
both of the RNAi lines, while the protein variant 201 (78 kDa)
only showed a decreased level of expression in Liprin-a4 knock-
down line 323. The Liprin-a4 isoform 202 protein was not
detected in this line. It was possible that the variant 202 was not
translated into protein or that the Liprin-a4 antibody did not
recognize this isoform. We investigated the phosphatase activity in
the presence of nickel in both the control and in the knock-down
line 323 (Figure 5A). The control showed an increasing activity
from 1.6 to 3.9 pmole/ug/min in the presence of nickel while in
the knock-down line 323, where Liprin-a4 was reduced by 50%,
the activity increased much less (0.6 to 1.0 pmole/ug/min). These
results showed that Liprin-a4 was necessary for the nickel-induced
activity of phosphatase. These results indicated that the variants
004 and 201 played a role in the cellular response to nickel. The
RNAi line was treated with various nickel concentrations for 24 h
and colony formation assay was performed (Figure 5B). Knock-
down of Liprin-a4 led to an increased sensitivity to nickel toxicity
in BEAS-2B (Figure 5B) and in A549 cell lines (data not shown).
For example, the survival rate for the control was 70% and it was
reduced to 53.8% in the knock-down line 323 after 0.25 mM
nickel treatment for 24 h, demonstrating a significantly higher
sensitivity of line 323 in comparison to control (Figure 5B).
Liprin-a4 was able to bind to nickel
Increased RNA and protein levels of Liprin-a4 were found after
nickel treatment and the knock-down line showed greater
sensitivity to nickel than did the control. In addition the increased
phosphatase activity in the presence of nickel was dependent on
Figure 3. Increases protein tyrosine phosphatase activity following nickel treatment. Free phosphates which were generated by
dephosphorylation reaction of the substrate were measured. (A) PTP activity was up regulated in BEAS-2B cells and A549 cells after 24 h nickel
treatment. (B) Un-treated control cells showed increased phosphatase activity when nickel was added to cell extracts (C) By western analysis we
demonstrated that the level of phosphorylated tyrosines in proteins was reduced in a concentration dependent manner after nickel treatment. This
finding correlates with the finding that the phosphatase activity was increased after nickel exposure.
doi:10.1371/journal.pone.0022764.g003
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to the cytoplasmic region of the receptor RPTP-LAR was
examined. Ni-NTA agarose was used to study the direct binding
of Liprin-a4 to nickel. It was known that Ni-NTA bound histidine
tagged proteins and was generally used for their purification. To
the best of our knowledge this experiment is the first time that Ni-
NTA agarose was used to study a specific protein binding to
nickel. Briefly, Ni-NTA and lysate were incubated over night.
Following this incubation, the Ni-NTA agarose was washed four
times with lysis buffer. The agarose interacting proteins were
Figure 4. Expression of Liprin-a4 in RNAi lines. The control pSUPER contains the vector without the RNAi construct and knock-down lines
contain the vector including the siRNA construct against Liprin-a4. (A) Liprin-a4 is 50% down regulated in 323 and it is decreased approximately 20%
in RNAi line 847. (B) Expression of isoform 004 is not detectable in RNAi line 323. The variant 201 is decreased in the knock-down 323 line. The
amount of Liprin-a4-202 is not changed in 323. (C) In Western analysis the RNAi lines show a reduced amount of Liprin-a4 isoform 004 (16 kDa) and
isoform 201 (78 kDa) in both knockdown lines (323 and 847). The isoform 201 shows a slight decrease in RNAi line 323.
doi:10.1371/journal.pone.0022764.g004
Figure 5. Cellular effects of Liprin-a4 knock-down in BEAS-2B cells. (A) In RNAi line 323 the PTP activity was slightly increased compared to
control. (B) Liprin-a4 RNAi line 323 showed a higher sensitivity to nickel induced cytotoxicity compared to the control.
doi:10.1371/journal.pone.0022764.g005
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antibody (Figure 6A). The direct binding of Liprin-a4 to nickel
was shown in the cytoplasmic protein extract by overnight
exposure to Ni-NTA agarose (Qiagen). This experiment suggested
a direct interaction between Liprin-a4 and nickel (Figure 6A) but
without a negative control the binding specificity was questionable.
We incubated SP-sepharose with nickel over night. After nickel
treatment the sepharose was incubated with cell lysate at 4uC over
night. Non specific sepharose protein binding was eliminated by
washing the sepharose four times with lysis buffer. The cleaned
sepharose samples were diluted in sample buffer and separated in
protein gel. The membrane was stained with the Liprin-a4
antibody. The direct binding of Liprin-a4 to nickel treated
sepharose was confirmed (Figure 6B) but there was no direct
binding of RPTP-LAR to nickel with Ni-NTA or with Ni treated
sepharose. Liprin-a4 was a crucial player in the response of BEAS-
2B cells to nickel. These results demonstrate that Liprin-a4 was a
direct binding partner of the receptor protein tyrosine phosphatase
RPTP-LAR and nickel.
Discussion
In this study Liprin-a4 expression was increased following nickel
treatment. Recently Mattauch et al. [16] had described an up-
regulation of Liprin-a4 in response to hypoxia. Its activation
occurred by binding of the hypoxia-inducible factor 1A (HIF-1A)
to HRE consensus binding site in the promoter region of Liprin-
a4. There are common mechanisms between nickel and hypoxia
in particular HIF-1A is stabilized by both nickel and hypoxia
treatment [17,18]. Nickel has been shown to inhibit the Prolyl-
hydroxylase that was responsible for marking HIF-1A for
degradation and nickel exposed cells exhibit hypoxia signaling
under normal oxygen. Following nickel exposure, Liprin-a4 was
up-regulated by the binding of HIF-1A to the HRE in the Liprin-
a4 promoter. Besides Ni(II) also Co(II) and to al lesser Cu(II),
Zn(II), As(III), Mn(II) and V(V) lead to a stabilization of HIF-1A
protein by inhibition of its hydroxylation [19] and this would
induce Liprin- a4 because it has an HRE in its promoter. Busch et
al. (2010) reported an increasing expression of Liprin- a4 after 3 h
treatment with Co [20]. Other metals such as Al(III) and Cd(II) do
not induce HIF-1A. It was shown that Chromium Cr(VI)
stabilized HIF-1A protein at a highly toxic doses after 4 h
exposure in A549 cells whereas after 24 h exposure in A549 to
chromium the protein HIF1A was not detected. We were unable
to measure any significant changes in Liprin-a4 expression after
24 h chromium treatment (Wu, data not published). The effect of
other metals on Liprin-a4 expression remains unclear.
Ni-induced Liprin-a4 expression seems to be due to the stabilized
HIF-1Aprotein which binds to HRE consensus site in the Liprin-a4
promoter and activates its expression. Furthermore Liprin-a4 did
not show a significant change in expression in Beas-2B cells
transformed by long-term exposure to nickel (Clancy, data not
published). This additional information seems to indicate a direct
function of Liprin-a4 in nickel-induced toxicity but not in
carcinogenicity since it is able to bind nickel ion. It is known that
several metal ions like nickel, cobalt and chromium induced
oxidative stress after cell treatment. Salnikov et al. (2000) showed
thatmetalsinducedtheproductionofreactiveoxygenspecies(ROS)
by activating hypoxia signaling under normal oxygen tension. This
formation of ROS is separate from the activation of HIF-1A
dependent genes including Liprin-a4 [19]. This information
indicates that stabilization of HIF-1A induces the overexpression
of Liprin-a4.Besides HIF-1Adependent inductionof Liprin- a4w e
have shown a transcriptional activation of the stress-inducible gene
HMOX1. This protective mechanism is mediated by transcription
factor nuclear erythroid 2-related factor2 (NRF2) that can regulate
expression of HMOX1 and other antioxidants [21]. Liprin-a4
seems to play a role in cellular protection against nickel-induced
toxicity. The oxidative stress has not been ruled out by the data
presented here, but induction of HIF-1a appears to be the main
mechanism by which Ni induces Liprin-a4 expression. The up-
regulation of Liprin-a4 in response to nickel was most likely
involved in attenuating the toxicity of nickel since there was an
increased sensitivity to nickel in a Liprin-a4 knock-down cell line.
Future investigations should include overexpression of Liprin-a4t o
analyze its potential of protection against nickel-induced toxicity.
Liprin-a4 is a member of the liprin family that contains an N-
terminal coiled-coil domain and the C-terminal domain includes
three sterile alpha motifs. The most studied member of the liprin
alpha family is Liprin-a1, which is an interaction partner of GIT,
KIF1A, ERC, EMS and GRIP [22,23,24,25]. Initially, Liprin-a1
was described as an interacting partner for receptor protein
tyrosine phosphatase RPTP-LAR that binds directly to the second
phosphatase domain of RPTP-LAR family members [23]. Besides
Liprin-a1, the multidomain protein trio also binds to the LAR
transmembrane tyrosine phosphatase [5,22]. This interaction
between Liprin-a1 is regulated by autophosphorylation on a
serine residue [2]. By sequence homology Liprin-a2/3 and 4
belong to this family. Here we showed a direct interaction of
Liprin-a4 with RPTP-LAR receptor protein that led to an
Figure 6. Liprin-a4 binds directly to Ni-NTA column. (A) Liprin-a4 binds directly to nickel-NTA agarose. (B) SP-Sepharose was pre-incubated
with nickel. Ni-sepharose is able to bind Liprin-a4.
doi:10.1371/journal.pone.0022764.g006
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this phosphatase was found after nickel treatment and in the
presence of nickel. In the absence of Liprin-a4, the phosphatase
activity is not significantly increased by nickel. This suggested a
direct connection between Liprin-a4, RPTP-LAR and nickel. So
far we have identified an interaction between Liprin-a4 and the
RPTP-LAR protein and between Liprin-a4 and nickel but not
between RPTP-LAR and nickel. It seems that nickel enhanced the
binding of Liprin-a4 to RPTP-LAR. Liprin-a4 and nickel were
necessary for the increased phosphatase activity. The binding of
Liprin-a4 to RPTP-LAR did not appear to be regulated by its
phosphorylation. In contrast, the tyrosine phosphorylation level
was decreased.
We have developed a model for Liprin-a4 and its role in the
cellular response to nickel (Figure 7). The activity of RPTP-LAR
remained at a basal activity level in the control and in Liprin-a4
knock-down line 323. In the presence of nickel, Liprin-a4 binds to
the second phosphatase domain of RPTP-LAR which is similar to
the interaction between RPTP-LAR and Liprin-a1. This interac-
tion could lead to a structural rearrangement of the first
phosphatase domain. Only the first domain of the RPTP-LAR
protein shows phosphatase activity. By reorganization of RPTP-
LAR, the first phosphatase domain might undergo conformational
arrangementsand becomemore openforitsphosphatasesubstrates.
The increasing activity of RPTP-LAR by Liprin- a4 seems to
play a special role in response to nickel. PTPs effect a number of
cell processes including cell growth, differentiation and the mitotic
cycle. The altered expression of Liprin- a4 and its resulting
increased RPTP-LAR activity may be related to a nickel- induced
stress response with as yet undetermined downstream effects.
Materials and Methods
Cell culture
HOS [26]and BEAS-2B [27]cells were grown in Dulbecco’s
Eagle’s medium (DMEM). BEP2D [28] cells were cultured in
LHC8 medium (GIBCO). BL41 [29] and Lymphocytes were
cultured in RPMI 1640 medium (Invitrogen). A549 [30] were
maintained in F-12K medium (Invitrogen). 10% fetal bovine
serum (FBS, ATLANTA biochemical’s) and 1% penicillin/
streptomycin (GIBCO) were added to all media. The cell lines
were cultured at 37uC in a humidified atmosphere of 5% CO2.
Cells were exposed to different concentrations of nickel (II)
chloride for 24 h. Transfected cells were treated with 0.1 uM
puromycin.
Colony formation assay
Cells were seeded at a density that yielded 80% confluence. The
following day, cells were exposed to various nickel concentrations
for 24 hours; cells were then trypsinized and counted and 300 cells
were seeded per 100 mm dish. After 2 weeks, media were
removed, dishes washed twice with cold PBS and stained with
Giemsa reagent for 30 min. Dishes were rinsed with water and
dried before manual counting.
Affymetrix Gene Chip expression
Total RNA was isolated from control and treated samples using
Trizol (Invitrogen) according to the manufacturer’s protocol.
Samples were purified with the RNaesy kit (QIAGEN). cDNA
probes were synthesized and labeled using Gene Chip Whole
Transcript cDNA Synthesis and Amplification Kit and Terminal
Figure 7. Increasing phosphatase activity in presence of nickel and Liprin-a4. The activity of RPTP-LAR remained at a basal activity level in
the control and in Liprin-a4 knock-down line 323. In the presence of nickel, Liprin-a4 binds to the second phosphatase domain (D2) of RPTP-LAR. By
reorganization of RPTP-LAR, the first phosphatase domain (D1) might undergo conformational arrangements and become more open for its
phosphate substrates.
doi:10.1371/journal.pone.0022764.g007
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Gene Chip Human Gene 1.0 ST Array (Affymetrix) that
contained 28,869 well annotated genes. Hybridization and
scanning of the arrays was performed using a standard procedure.
Microarray data was analyzed using GeneSpring v11 (Agilent
Technologies). The expression value of each probe set was
determined after quantile normalization using RMA16 algorithm
and baseline transformation to the median levels of all samples.
Antibodies
The following antibodies were obtained from commercial suppliers:
Monoclonal mouse anti-Liprin-a4 (ab56339), Abcam and Monoclo-
nal mouse alpha Tubulin (T9026) Sigma-Aldrich. The antibodies p-
Tyrosine (PY350), RPTP-LAR (R-20): sc1119, anti-goat IgG-HRP
(sc-2384), anti- mouse IgG-HRP, normal IgG (sc-2028) and Protein
A/G Plus-agarose (sc2003) were purchased from Santa Cruz.
RNAi interference and transfection
Short interfering RNA for Liprin-a4 was cloned to form a
hairpin structure in vector pSUPER (Oligoengine) according to
the manual. The sequences of the siRNA against Liprin-a4 were
as follows: Liprin-a4-847 59-GCAGCTGGATGCCATCAAT- 39
and Liprin-a4-323 59 CCATTAGAAGATCCTTCTT- 39. Ex-
actly 1 ug of vector with and without RNAi construct was
transfected into BEAS-2B and A549 cells according to the
Lipofectamine Plus (Invitrogen) protocol.
RNA isolation and RT-PCR
RNA was isolated with Trizol following the manufacturers
protocol. RNA was purified with 8 M LiCl for 2 h on ice and
precipitated with 1/10 volume NaAc, followed by 2.5 times the
volume of 100% ethanol over night at 220uC. The purified RNA
was used for RT-PCR with random primer and Liprin-a4 isoform
specific reverse primer with Superscript III (Invitrogen). The
isoform specific PCR was performed with Maxima Hot Start
polymerase (Fermentas) with 58uC annealing and one min at
72uC. The following primers were used: F1- GAGCTGGCCCA-
GAGAATTGCAGC, R1- TGGTGCTGCTCCTCAATCTG-
CCG, F1b- GAGATCG GCATCAGCAATGCCCTG, 1b-
CCATTCATTCCCAATCCACTCATG, F2- GCGTCTG CA-
GCTCCACCTGAAGG, F4- GCCGTTTGTGGATGGCGTC-
CAC and R2- CAATGCCGAG TAGCGGCGATGCAC. The
quantitative PCR was conducted using ABI 7300 detection system
with Power Sybr Green (ABI). The following primers were used
for normalization EIF4EBP2F7139 AGAGGACAC TCACG-
TGCTAAGGT, EIF4EBP2R7274 CAGTCTCCGCTTTTC-
CATTCA and for the genes of interest Liprin-a4F974 CAG-
CATGGAAGCCCTAAACCT, Liprin-a4R1076 GGA CAGGG-
CCGTCAGAGA, CA9F1284rt CATCCTAGCCCTGGTTT-
TTGG, CA9-R1365rt CCTTCTG TGCTGCCTTCTCAT,
HMOX1 F1212 GCCCTTCAGCATCCTCAGTTC, HMO
X1R1280 GGTTTGAGACAGCTGCCACAT, NDRG1F654rt
TACCGCCAGCACATTGTGAAT and NDRG1 R723rt
GGCTGTTGTAGGCATTGATGAA in different cell lines after
nickel exposure. For quantitative Real time PCR the primers were
designed with primer express 3.0 (ABI).
Protein isolation, Western
Cells were cultured in 150 mm dishes, washed twice with PBS
and once with PBS/1 mM EDTA. Cells were scraped in PBS/
1 mM EDTA. The cells were resuspended in buffer (10 mM
HEPES pH 7.9, 50 mM NaCl, 0.5 M Sucrose, 0.1 mM EDTA,
0.5% Triton X100, freshly added 1 mM DTT, 1 mM PMSF,
Roche proteinase inhibitor). After incubation on ice the suspension
(cytoplasmic/membrane fraction) was placed in a new tube. This
fraction was used for Western analysis. The pellet (nuclear fraction)
was washed with buffer A (10 mM HEPES pH 7.9, 10 mM KCl,
0.1 mM EDTA, 0.1 mM EGTA, freshly added 1 mM DTT,
1 mM PMSF, Roche proteinase inhibitor). The nuclear extract was
diluted in buffer 26C (10 mM HEPES pH 7.9, 500 mM NaCl,
0.1 mM EDTA, 0.1 mM EGTA, 0.1% IGEPAL add 1 mM DTT,
1 mM PMSF, Roche proteinase inhibitor). The protein concentra-
tion was determined using the Bio-Rad protein assay and 50 ug
protein from cytoplasmic/membrane fractions were separated by
10% SDS-PAGE gel and transferred to polyvinylidene difluoride
(PVDF) membranes. Immunoblotting was performed using anti-
bodies Tubulin, Liprin-a4, RPTP-LAR and p-Tyrosine. Concen-
trations of the antibodies were utilized depending upon the
recommendations of the suppliers.
Immunoprecipitation
Cells were lysed with RIPA buffer for the immunoprecipitation
(IP) experiment. Control IgG was used to remove non specific
binding proteins. The IP experiment was performed with RPTP-
LAR antibody or Liprin-a4 or pTyrosine antibody according to
the Santa Cruz protocol. The precleaned lysate was also incubated
with Ni-NTA agarose (QIAGEN) and to SP-Sepharose Fast Flow
(GE Healthcare, 17-0729-10) in the presence nickel (II) chloride
(SIGMA) overnight at 4uC. The IP samples were washed four
times with RIPA buffer. Proteins were loaded on 8%, 10% or 12%
acrylamide gels. Concentrations of the antibodies were utilized
depending upon the recommendations of the suppliers.
PTP assay
Cells were maintained in 150 mm dishes, washed twice with
0.9% NaCl and diluted in lysis buffer (50 mM HEPES pH 7.4,
0.5% Triton X100, 10% Glycerol, Protease inhibitor Roche,
1 mM PMSF). Control IgG was used to remove non specific
binding proteins. The precleaned cell lysate was incubated with
RPTP-LAR antibody and Protein A overnight at 4uC. The IP
samples were washed four times with lysis buffer and eluated with
10 mM Imidazol. The protein concentration was determined
using the Bio-Rad DC protein assay, and 50 ug proteins were
separated by 10% SDS-PAGE gel. The tyrosine phosphatase assay
was performed according to the instruction of the ‘‘protein
tyrosine phosphatase assays kit’’ (Sigma-Aldrich). We used
Monophosphate Substrate (PTP Substrate 1) [pTyr1146] Insulin
Receptor (1142–1153) as substrate for RPTP-LAR. Experiment
was repeated several times.
Cells were diluted in lysis buffer (50 mM HEPES pH 7.4, 0.5%
Triton X100, 10% Glycerol, Protease inhibitor Roche, 1 mM
PMSF). The PTP assay was perfomed with the lysate according to
the instruction of the ‘‘protein tyrosine phosphatase assays kit’’
(Sigma-Aldrich, Figure S2). We got reproducible results.
Supporting Information
Figure S1 Validation of Affymetrix GeneChip data from BEAS-
2B cells exposed to NiCl2 with quantitative real time PCR. We
found an increased expression of Liprin-a4, CA9, NDRG1 and
HMOX1 after nickel treatment. These four genes remain
unchanged in control.
(TIF)
Figure S2 Phosphatase activity is increased after Nickel
treatment in a concentration dependent manner in BEP2D and
HOS cells.
(TIF)
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